Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2011-12-22 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NEMOURS (77140), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BONHOMME : revenue, balance sheet and financial ratios
PHARMACIE BONHOMME is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NEMOURS (77140),
this company of category PME
shows in 2025 a net income positive of 150 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BONHOMME (SIREN 538722703)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
149 876 €
226 913 €
256 964 €
151 087 €
93 529 €
79 533 €
75 704 €
-79 409 €
6 516 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BONHOMME generates positive net income of 150 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 7 k€ -> 150 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
149 876 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 155%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
155.186%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
10.386%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
544.836
1035.727
650.229
452.331
316.939
209.794
126.468
62.849
155.186
Financial autonomy
14.167
7.969
11.591
15.414
20.641
26.141
35.34
46.462
10.386
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
155.192025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+13 pts over 3 years
In 2025, the debt ratio of PHARMACIE BONHOMME (155.19) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
10.39%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch-9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BONHOMME (10.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 48.47. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
48.471
Liquidity indicators evolution PHARMACIE BONHOMME
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
146.97
123.617
123.173
123.004
119.708
121.836
149.876
152.074
48.471
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
48.472025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-17 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BONHOMME (48.47) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE BONHOMME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BONHOMME is estimated at
2 380 798 €
(range 1 615 620€ - 3 735 800€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1615k€2380k€3735k€
2 380 798 €Range: 1 615 620€ - 3 735 800€
NAF 5 année 2025
Valuation method used
Net Income Multiple
149 876 €
×
15.9x
=2 380 798 €
Range: 1 615 621€ - 3 735 800€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BONHOMME with other companies in the same sector:
Frequently asked questions about PHARMACIE BONHOMME
What is the revenue of PHARMACIE BONHOMME ?
The revenue of PHARMACIE BONHOMME is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BONHOMME profitable?
Yes, PHARMACIE BONHOMME generated a net profit of 150 k€ in 2025.
Where is the headquarters of PHARMACIE BONHOMME ?
The headquarters of PHARMACIE BONHOMME is located in NEMOURS (77140), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE BONHOMME ?
The tax return of PHARMACIE BONHOMME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BONHOMME operate?
PHARMACIE BONHOMME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart